This country profile provides an overview of Mozambique’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage decreased from 81% in 2018 to 49% in 2019.
Treatment coverage increased from 20% in 2018 to 80% in 2019.
Treatment coverage increased from 51% in 2018 to 56% in 2019.
Treatment coverage increased from 60% in 2018 to 96% in 2019.
Mozambique does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mozambique.